Trident Texofab Hits 52-Week High, Outperforms Sector and Sensex with 161.86% Increase

Oct 28 2024 09:36 AM IST
share
Share Via
Trident Texofab, a microcap trading company, has hit a 52-week high on October 28, 2024. With a 'Sell' call by MarketsMojo, the stock has gained 5% and reached an intraday high of Rs 115.61. It has consistently risen for 15 days, showing a remarkable increase of 161.86%. The stock has outperformed the sector and is trading higher than its moving averages, indicating a positive trend. Compared to the Sensex, Trident Texofab has shown a strong 1-year performance of 78.14%, showcasing its potential for growth and market outperformance. Investors should monitor the company's performance, but seek professional advice before investing.

Trident Texofab, a microcap trading company, has recently hit a 52-week high on October 28, 2024. The stock has been performing well in the market, with a 'Sell' call by MarketsMOJO. Today, the stock opened with a gain of 5% and touched an intraday high of Rs 115.61. It has been consistently gaining for the past 15 days and has seen a remarkable increase of 161.86% in this period.

The company's stock has outperformed the sector by 4.25% and is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the stock's performance.

In comparison to the Sensex, Trident Texofab has shown a strong 1-year performance of 78.14%, while the Sensex has only seen a 24.84% increase. This showcases the company's potential for growth and its ability to outperform the market.

Investors should keep an eye on Trident Texofab as it continues to show promising performance in the trading industry. However, it is important to do thorough research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Trident Texofab falling/rising?
Dec 12 2025 01:10 AM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Dec 05 2025 08:41 AM IST
share
Share Via
Is Trident Texofab technically bullish or bearish?
Dec 04 2025 08:47 AM IST
share
Share Via
How has been the historical performance of Trident Texofab?
Dec 03 2025 10:55 PM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Nov 19 2025 08:10 AM IST
share
Share Via